Anti-CD134 / OX40L receptor antibody [BLR042F]
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal CD134 / OX40L receptor antibody. Suitable for ICC, IP, Flow Cyt, WB, IHC-P and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human TNFRSF4.
View Alternative Names
CD134, TXGP1L, TNFRSF4, Tumor necrosis factor receptor superfamily member 4, ACT35 antigen, OX40L receptor, TAX transcriptionally-activated glycoprotein 1 receptor
- ICC
Unknown
Immunocytochemistry - Anti-CD134 / OX40L receptor antibody [BLR042F] (AB243898)
Formalin-fixed, paraffin-embedded MJ cells labeling CD134 / OX40L using ab243898 at 1/250 dilution in ICC analysis. A HRP-conjugated goat-anti rabbit IgG was used as the secondary. DAB staining.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD134 / OX40L receptor antibody [BLR042F] (AB243898)
Formalin-fixed, paraffin-embedded human lung carcinoma tissue stained for CD134 / OX40L using ab243898 at 1/250 dilution in immunohistochemical analysis. A HRP-conjugated goat anti-rabbit antibody was used as the secondary. DAB staining.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD134 / OX40L receptor antibody [BLR042F] (AB243898)
Immunohistochemical analysis of formalin-fixed, parafin-embedded human breast carcinoma tissue labeling CD134 / OX40L with ab243898 at 1/250 dilution, followed by HRP-conjugated Goat Anti-Rabbit IgG secondary antibody. Counter stained with DAPI. Opal staining.
- IP
Unknown
Immunoprecipitation - Anti-CD134 / OX40L receptor antibody [BLR042F] (AB243898)
CD134 / OX40L was immunoprecipitated from 1.0 mg MJ whole cell lysate with ab243898 at 20 µl per reaction. Western blot was performed on the immunoprecipitate using ab243898 at 1/1000 dilution. Lane 1 : ab243898 IP in MJ whole cell lysate.
Lane 2 : Control IgG in MJ whole cell lysate.
Detection : Chemiluminescence with an exposure time of 30 seconds.
All lanes:
Immunoprecipitation - Anti-CD134 / OX40L receptor antibody [BLR042F] (ab243898)
Predicted band size: 29 kDa
false
- WB
Unknown
Western blot - Anti-CD134 / OX40L receptor antibody [BLR042F] (AB243898)
Western blot analysis using ab243898 at 1/1000 dilution.
Lane 1 : HEK-293T whole cell lysate (50 µg).
Lane 2 : MCF7 whole cell lysate (50 µg).
Lane 3 : HepG2 whole cell lysate (50 µg).
Lane 4 : A549 whole cell lysate (50 µg).
Lane 5 : SW 620 whole cell lysate (50 µg).
Lane 6 : SK whole cell lysate (50 µg).
Lane 7 : Jurkat whole cell lysate (50 µg).
Lane 8 : TCMK-1 whole cell lysate (50 µg).
Lane 9 : NIH/3T3 whole cell lysate (50 µg).
A HRP-conjugated goat anti-rabbit IgG antibody was used as the secondary. Detection : chemiluminescence with an exposure time of 10 seconds.
All lanes:
Western blot - Anti-CD134 / OX40L receptor antibody [BLR042F] (ab243898)
Predicted band size: 29 kDa
false
Reactivity data
Product details
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
This product is sold under License from Bethyl Laboratories, Inc.
Properties and storage information
Form
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CD134 influences T cell proliferation survival and memory formation being an important component of the immune system's adaptive response. OX40L engagement with CD134 enhances the activation and survival of T cells promoting long-term immunity. This interaction does not form part of a larger complex but functions as a direct signaling mechanism that augments T cell receptor (TCR) signaling leading to increased cytokine production and sustained immune responses essential for controlling infections and cancer.
Pathways
CD134 signaling intersects with the nuclear factor-kappa B (NF-κB) and phosphoinositide 3-kinase (PI3K) pathways. These pathways play significant roles in regulating immune responses and cell survival. Through the NF-κB pathway CD134 influences gene transcription related to immune activation. It also connects with other immune regulatory proteins such as CD28 which further potentiates T cell responses and enhances effector functions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Oncology research 33:1679-1693 PubMed40612868
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com